Welcome to the research group DILiS

Data Integration in the Life Sciences (DILiS)

For many problems in the life sciences, different types of data have been generated and provide different views. Each data layer comes with its own limitations, errors and biases, so their integrative analysis is key for robust conclusions in order to understand complex phenomena. Our research group Data Integration in the Life Sciences (DILiS) leverages different methods for data analysis: machine learning enables the detection of patterns from unstructured data, but large deep learning models usually require large amounts of data. Networks allow representing interactions between entities and are highly informative. Straightforwardly, they enable the combined analysis of different data views. Dynamical models capture temporal behaviors and complex, intricate relationships. In addition to using these methods and their strengths separately, we are interested in combining machine learning, network-based analysis and mathematical modeling of dynamic processes. We are thereby especially interested in how the latter two can be used to include prior information (domain knowledge) into the prediction pipelines. Applications stem mainly from a biomedical background, such as drug response prediction, and we focus on integrating different kinds of data with biomolecular, "multi-omics" data.

Get to know our group


Latest News

May 29, 2026: Una Europa

Katharina Baum attended the Una Europa general assembly in Paris. Had a great time discussing with international researchers how they envision advancing the fast-developing field of Data Science and AI.

May 18, 2026: Simulation-based transfer learning

Published a new paper in BMC Bioinformatics presenting a systematic pipeline to optimize and select the best synthetic, ODE-based data configurations when real biological training data is scarce.

May 12, 2026: DrEval paper published at Nature Communications

Judith Bernett and Pascal Iversen, together with collaborators, found that most published ML models for predicting cancer drug response don't actually outperform simple baselines under rigorous testing; so they built DrEval, a new evaluation pipeline, now published in Nature Communications.

GitHub

Visit our group GitHub to explore our latest open-source pipelines, software packages, and computational tools.


Topic revision: r15 - 23 Jun 2026, Renka01UserTopic
This site is powered by FoswikiCopyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Foswiki? Send feedback